AVDL
Price
$7.51
Change
-$0.32 (-4.09%)
Updated
Apr 1 closing price
Capitalization
1.53B
40 days until earnings call
RMTI
Price
$1.08
Change
-$0.05 (-4.42%)
Updated
Apr 1 closing price
Capitalization
49.87M
47 days until earnings call
Ad is loading...

AVDL vs RMTI

Header iconAVDL vs RMTI Comparison
Open Charts AVDL vs RMTIBanner chart's image
Avadel Pharmaceuticals
Price$7.51
Change-$0.32 (-4.09%)
Volume$880.14K
Capitalization1.53B
Rockwell Medical
Price$1.08
Change-$0.05 (-4.42%)
Volume$194.79K
Capitalization49.87M
AVDL vs RMTI Comparison Chart
Loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. RMTI commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a StrongBuy and RMTI is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (AVDL: $7.83 vs. RMTI: $1.13)
Brand notoriety: AVDL: Notable vs. RMTI: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVDL: 58% vs. RMTI: 59%
Market capitalization -- AVDL: $1.53B vs. RMTI: $49.87M
AVDL [@Pharmaceuticals: Other] is valued at $1.53B. RMTI’s [@Pharmaceuticals: Other] market capitalization is $49.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 3 TA indicator(s) are bullish while RMTI’s TA Score has 4 bullish TA indicator(s).

  • AVDL’s TA Score: 3 bullish, 5 bearish.
  • RMTI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RMTI is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Other) experienced а -8.21% price change this week, while RMTI (@Pharmaceuticals: Other) price change was -10.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.28%. For the same industry, the average monthly price growth was -2.37%, and the average quarterly price growth was +50.06%.

Reported Earning Dates

AVDL is expected to report earnings on May 12, 2025.

RMTI is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL($1.53B) has a higher market cap than RMTI($49.9M). AVDL YTD gains are higher at: -25.500 vs. RMTI (-44.608). RMTI has higher annual earnings (EBITDA): -4.69M vs. AVDL (-149.12M). AVDL has more cash in the bank: 105M vs. RMTI (10.9M). AVDL has less debt than RMTI: AVDL (2.62M) vs RMTI (13.4M). RMTI has higher revenues than AVDL: RMTI (83.6M) vs AVDL (28M).
AVDLRMTIAVDL / RMTI
Capitalization1.53B49.9M3,066%
EBITDA-149.12M-4.69M3,177%
Gain YTD-25.500-44.60857%
P/E RatioN/AN/A-
Revenue28M83.6M33%
Total Cash105M10.9M963%
Total Debt2.62M13.4M20%
FUNDAMENTALS RATINGS
AVDL vs RMTI: Fundamental Ratings
AVDL
RMTI
OUTLOOK RATING
1..100
6853
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
6495
P/E GROWTH RATING
1..100
42100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (43) in the Medical Specialties industry is somewhat better than the same rating for AVDL (79). This means that RMTI’s stock grew somewhat faster than AVDL’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AVDL (100). This means that RMTI’s stock grew similarly to AVDL’s over the last 12 months.

RMTI's SMR Rating (92) in the Medical Specialties industry is in the same range as AVDL (98). This means that RMTI’s stock grew similarly to AVDL’s over the last 12 months.

AVDL's Price Growth Rating (64) in the Medical Specialties industry is in the same range as RMTI (95). This means that AVDL’s stock grew similarly to RMTI’s over the last 12 months.

AVDL's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for RMTI (100). This means that AVDL’s stock grew somewhat faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLRMTI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 26 days ago
83%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWGAX12.68N/A
N/A
American Century International Gr A
DRLYX8.14N/A
N/A
BNY Mellon Developed Markets RE Scs - Y
DISIX21.79N/A
N/A
BNY Mellon Small Cap Stock Index I
SBEMX9.32N/A
N/A
Segall Bryant & Hamill Em Mkts Instl
TRZSX13.52N/A
N/A
T. Rowe Price Overseas Stock Z